Target Group Inc. SEC filings CBDY
Target Group Inc. has 254 filings in SEC EDGAR's recent list, going back to Sep 30, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 18, 2025 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 10, 2019 | — |
| S-1 | Registration statement | Jun 13, 2017 | — |
| S-8 | Employee stock plan registration | May 12, 2017 | — |
| 424B3 | Prospectus | Dec 21, 2015 | — |
| S-8 | Employee stock plan registration | Nov 25, 2015 | — |
| S-1/A | Amended registration statement | Jul 6, 2015 | — |
| S-1/A | Amended registration statement | Jun 23, 2015 | — |
| S-1/A | Amended registration statement | May 22, 2015 | — |
| S-1/A | Amended registration statement | Jan 26, 2015 | — |
| S-1 | Registration statement | Dec 11, 2014 | — |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hamilton
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1586554
- Former names
- Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.